Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

PET Imaging of Subjects Using 124I-PU-AD: A Pilot Study

Authors not listed

Samus Therapeutics, Inc. · 2016

Abstract

This is a first in-human, open-label pilot (microdose) study of the positron-emitting agent 124I-PU-AD in subjects with specific cancer types (solid malignancy, lymphoma, and/or myeloma) and/or Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-02 MST

Cite this

APA
Anonymous. (2016). PET Imaging of Subjects Using 124I-PU-AD: A Pilot Study. <em>Samus Therapeutics, Inc.</em>. https://clinicaltrials.gov/study/NCT03371420
Vancouver
Anonymous. PET Imaging of Subjects Using 124I-PU-AD: A Pilot Study. Samus Therapeutics, Inc.. 2016.
BibTeX
@misc{anon2016PETIma, title = {PET Imaging of Subjects Using 124I-PU-AD: A Pilot Study}, author = {Anonymous}, journal = {Samus Therapeutics, Inc.}, year = {2016}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings